Clinical Trial Detail

NCT ID NCT03051035
Title First-in-Human Study of KO-947 in Non-Hematological Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Kura Oncology, Inc.
Indications

Advanced Solid Tumor

Therapies

KO-947

Age Groups: adult senior

Additional content available in CKB BOOST